Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, 24-Week, Multicenter, Randomized, Parallel-Group, Dose-Ranging Study To Evaluate The Effect Of Teriparatide Nasal Spray On Bone Mineral Density In Postmenopausal Women With Low Bone Mineral Density

NCT00624481 is registered in ClinicalTrials.gov with Nastech Pharmaceutical Company, Inc. as lead sponsor.

NCT NCT00624481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00624481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, 24-Week, Multicenter, Randomized, Parallel-Group, Dose-Ranging Study To Evaluate The Effect Of Teriparatide Nasal Spray On Bone Mineral Density In Postmenopausal Women With Low Bone Mineral Density
Lead sponsor
Nastech Pharmaceutical Company, Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2008
Completion date
April 30, 2009
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, osteoporosis